tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Humana Lowers 2025 GAAP EPS Guidance

Story Highlights
Humana Lowers 2025 GAAP EPS Guidance

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Humana ( (HUM) ) has shared an announcement.

Humana Inc. reported its financial results for the second quarter of 2025, highlighting a GAAP earnings per share (EPS) of $4.51 and an adjusted EPS of $6.27. The company has revised its full-year 2025 guidance, lowering GAAP EPS expectations to approximately $13.77 while raising adjusted EPS guidance to approximately $17.00. Humana also increased its revenue guidance to at least $128 billion and adjusted its Medicare Advantage membership projections to a decline of up to 500,000 members, reflecting strategic exits from unprofitable plans. The company continues to expand its CenterWell operations and launched a new Medicaid contract in Virginia, indicating a focus on sustainable growth and value creation.

The most recent analyst rating on (HUM) stock is a Buy with a $316.00 price target. To see the full list of analyst forecasts on Humana stock, see the HUM Stock Forecast page.

Spark’s Take on HUM Stock

According to Spark, TipRanks’ AI Analyst, HUM is a Outperform.

Humana’s strong financial performance and strategic initiatives in the healthcare sector underpin its overall stock score. Despite a challenging regulatory environment and mixed technical indicators, the company’s robust revenue growth, efficient cash generation, and reasonable valuation support a positive outlook. However, attention to external risks and operational efficiency remain critical for sustained growth.

To see Spark’s full report on HUM stock, click here.

More about Humana

Humana Inc. operates in the healthcare industry, primarily offering health insurance products and services. The company focuses on Medicare Advantage plans, Medicaid, and other health-related services, with a strategic emphasis on expanding its CenterWell and Medicaid operations.

Average Trading Volume: 1,743,182

Technical Sentiment Signal: Sell

Current Market Cap: $27.94B

Learn more about HUM stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1